Abstract In Alagille syndrome, routine follow-up imaging of the liver plays an important role in detecting early parenchymal changes and to evaluate portal hypertension. Modern contrast-enhanced imaging methods not only allow early detection of focal liver lesions, but also enable further characterization of their nature and guide biopsy procedures. We present the US and MR imaging findings of hepatocellular carcinoma and a regenerating nodule in a 3-year-old child with Alagille syndrome.
Introduction
Alagille syndrome is a rare, congenital disease with a prevalence of 1:70,000 births that is associated with a microdeletion of the short arm of chromosome 20 [1] . Infants present in the first days of life with jaundice as a result of chronic intrahepatic cholestasis due to paucity and hypoplasia of the intralobular bile ducts [1] . Malformations of the face, heart, skeleton and kidneys are related [1] . The initial evaluation of the child includes a clinical examination, laboratory tests and imaging of the liver. Liver biopsy and molecular genetic work-up finally establishes the diagnosis of Alagille syndrome.
Intrahepatic cholestasis causes biliary cirrhosis and the only curative treatment remains liver transplantation. Few cases of associated hepatic nodular lesions such as hepatocellular carcinoma (HCC) or hepatic nodular hyperplasia (HNH) have been reported [2] [3] [4] .
We describe the US and MR imaging findings of the liver in a 3-year-old child with Alagille syndrome and histological confirmed HCC and regenerating nodule.
Case report
At 13 weeks old, our patient was admitted to the gastroenterology clinic because of jaundice. Alagille syndrome was diagnosed due to the findings of persistent jaundice, peripheral pulmonary artery stenosis, typical facies and butterfly vertebrae (Fig. 1) . The diagnosis was established with a de novo mutation of the protein-encoding JAG1-region of chromosome 20.
In addition to clinical follow-up, liver US was performed every 6 months. At the age of 10 months the child developed biliary cirrhosis with hepato-splenomegaly, portal hypertension and oesophageal varices grade I. At the age of 36 months nodular changes of the liver parenchyma were noted. There was a hypoechoic, 2.7-cm well-defined liver lesion in segment VI/VII and another large, isoechoic nodular lesion in segment V displacing the adjacent vessels (Fig. 2) .
Since there were new focal liver lesions with different sonographic echotextures and elevated alpha fetoprotein (AFP) levels, these lesions were further characterized with a standard paediatric MRI-liver protocol and dynamic contrast-enhanced sequences with gadolinium using a 1.5-T magnet (Figs. 3 and 4) .
The liver lesion in segment VI/VII showed slight hyperintense signal on the T2-W sequence and hypointense signal on the T1-W sequence. The lesion was characterized by early enhancement in the arterial phase and a wash-out phenomenon in the late phases on the dynamic contrast-enhanced images. This enhancement pattern was consistent with a malignant lesion, most likely a HCC. The larger liver lesion in segment V had similar intensity to liver parenchyma on all sequences and the T1-W dynamic contrast-enhanced images showed isointense signal in all phases with central hypointense signal and a prominent central vessel. This enhancement pattern was consistent with a HNH. A biopsy of the likely malignant lesion confirmed a moderately differentiated HCC.
As the only curative option, orthotopic liver transplantation was performed and histological investigation of the liver confirmed the diagnosis of HCC of the smaller lesion and regenerating nodule of the larger lesion.
Discussion
There are only a few reported cases in the literature of associated liver tumours (HCC and HNH) in Alagille syndrome and the youngest child described is a 17-monthold boy [2] [3] [4] [5] .
US is the imaging method of choice for the first evaluation and routine follow-up examination of the liver in children. An inhomogeneous and echogenic liver parenchyma may be seen due to steatosis, fibrosis and/or cirrhosis of the liver. Blane et al. [6] described that liver lesions in children cannot be characterized using US alone and further imaging methods must be performed. Dynamic contrastenhanced US (CEUS) imaging of focal liver lesions is a promising technique, but still not approved for children. Contrast-enhanced dynamic techniques are used to differentiate among vascular lesions, HNH or malignant lesions demonstrating a characteristic enhancement pattern (reported sensitivity of HCC >1 cm with dynamic contrast imaging is up to 87% with a specificity of 79% [7] . For benign liver lesions the accuracy is 83.1% [8] .) MRI and US are both methods without ionizing radiation and with good soft-tissue contrast. The advantage of MRI is a significantly better overview of the liver and the detection of several lesions at the same time, while in CEUS only part of the liver per administration of contrast medium may be continuously imaged. On the other hand, there is usually no need for sedation or anaesthesia when performing CEUS.
The MRI findings in our case showed a different contrast-enhancement pattern between the malignant (early enhancement and wash-out) and the benign liver lesion. The regenerating nodule showed an isointense enhancement pattern, a central hypointense scar and a prominent central vessel that has been described in the literature to be consistent with HNH [5] .
In summary, Alagille syndrome is a rare disease resulting in cirrhosis of the liver in children. Complications include focal liver lesions such as HCC and US follow-up studies are mandatory to detect them as early as possible. Contrastenhanced dynamic imaging of the liver is recommended to characterize these lesions and plays an important role for further management. 
